Events & Presentations

CHOOSE A YEAR
2022-11-29

Biofit Conference 2022, November 29-30, 2022, Strasbourg, France

AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference

AiCubator

A new way of collaboration in the field of anti-infectives

With more than 1,000 international actors from 35+ countries, such as big pharma, emerging and small biotech, diagnostic companies, pre-seed / seed / Series A investors, as well as professionals from tech transfer, academia and research institutions, BioFIT is the leading partnering event in Europe for technology transfer, academia-industry collaborations and early-stage innovation deals in the field of Life Sciences. BioFIT is also the European marketplace for pre-seed, seed and Series A investment rounds in Life Sciences. 

If you want to learn about the AiCubator, AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference.

2022-11-17

Pharma partnering Summit US 2022, November 17-18, 2022, Boston, USA

AiCuris will participate at Bio Europe 2022 conference.

Meet us at Pharma partnering Summit

The Pharma Partnering US Summit 2022 is one of the most prestigious physical events of 2022 on the US East Coast for life science professionals. This platform brings together senior executives from different parts of the world, focused on Licensing, R&D Collaborations, Commercialisation & Distribution deals, Fundraising, Investing, M&A, Going Public as well as partnering opportunities in the broader aspects.

If you are looking for partnering opportunities in the field of anti-infectives – meet AiCuris at Pharma Partnering US Summit 2022!

2022-11-07

7th International Symposium on Antimicrobial PEPTIDES – AMP2022, November 7-9, 2022, Paris, France

AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference

AiCubator

A new way of collaboration in the field of anti-infectives

AMP 2022 will bring together the world’s leading experts in the field to discuss the most recent research advances on: a) the discovery, biosynthesis pathways and bioengineering of novel antimicrobial peptides, b) the mechanisms of antimicrobial activities and bacterial resistance, c) immune modulation by antimicrobial peptides, d) the interplay between antimicrobial peptides & microbiota, and e) antimicrobial peptides in the One Health context and applications. The 7th International Symposium on Antimicrobial Peptides is supported by the French Society on Antimicrobial Peptides (SF-PAM) and by the National Museum of Natural History which will participate to the organization and social activities of the Symposium. 

If you want to learn about the AiCubator, AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference.

2022-10-24

Bio Europe 2022, October 24-26, 2022, Leipzig, Germany

AiCuris will participate at Bio Europe 2022 conference.

Meet us in Leipzig at Bio Europe

BIO-Europe® is scheduled to take place October 24–26 in Leipzig, Germany. This will be the first in-person BIO-Europe since its 2019 edition in Hamburg, Germany. It’s time to build real bridges with real people again. There’s no better place to do that than in lovely Leipzig, the city with more bridges than Venice, at BIO-Europe, the biggest in Europe, and probably the best, partnering conference in our industry. 

If you are looking for partnering opportunities in the field of anti-infectives – meet AiCuris at Bio Europe 2022!

2022-10-19

IDWeek, Oct. 19 – 23, 2022, Washington/DC USA

AiCuris will participate at IDWeek 2022 conference

Meet us in Washington/DC at IDWeek

IDWeek is the prime annual conference for all parties interested in research and development of new anti-infective treatments.

Join AiCuris in learning about novel achievements in the world of anti-infectives!

2022-10-04

ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance, October 4-7, 2022, Dublin, Ireland

AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference

AiCubator

A new way of collaboration in the field of anti-infectives

Antimicrobial drug resistance (AMR) is an urgent global health problem. New antimicrobial drug development is increasingly viewed as a priority by national and international bodies. Co-sponsored by the American Society for Microbiology (ASM) and the European Society for Clinical Microbiology and Infectious Diseases (ESCMID), this multidisciplinary meeting will address the challenges, opportunities and current requirements for antimicrobial drug development to address antimicrobial resistance. 

If you want to learn about the AiCubator, AiCuris corporate incubator, to apply for the resident status or looking for a partnering opportunity in an anti-infective field – meet us at the conference.

2022-09-28

BioPharm America 2022, September 28-29, 2022, Boston, USA

AiCuris will participate at BioPharm America 2022 conference.

Meet us at BioPharm America

BioPharm America, proudly part of Biotech Week Boston, is the event driving the future of drug development by bringing together the most innovative companies with leaders across the life science value chain. 

If you are looking for partnering opportunities in the field of anti-infectives – meet AiCuris at BioPharm America 2022!

2022-09-08

22nd Symposium of the International Immunocompromised Host Society Annual Congress of the Swiss Society for Allergology and Immunology, September 8 - 11 2022, Basel, Switzerland

AiCuris: The Powerhouse for Anti-infectives - Committed to making the difference

Visit our poster with the title "Immunocompromised Patients with Resistant HSV Infections: The International Early Access Program of Pritelivir"

Program:

Poster assembly - Title:

"Immunocompromised Patients with Resistant HSV Infections: The International Early Access Program of Pritelivir"

Poster number:
P75